ZA200203178B - New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist. - Google Patents

New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist.

Info

Publication number
ZA200203178B
ZA200203178B ZA200203178A ZA200203178A ZA200203178B ZA 200203178 B ZA200203178 B ZA 200203178B ZA 200203178 A ZA200203178 A ZA 200203178A ZA 200203178 A ZA200203178 A ZA 200203178A ZA 200203178 B ZA200203178 B ZA 200203178B
Authority
ZA
South Africa
Prior art keywords
beta
new combination
adreno
receptor antagonist
receptor agonist
Prior art date
Application number
ZA200203178A
Inventor
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200203178B publication Critical patent/ZA200203178B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA200203178A 1999-11-03 2002-04-22 New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist. ZA200203178B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9903995A SE9903995D0 (en) 1999-11-03 1999-11-03 New combination

Publications (1)

Publication Number Publication Date
ZA200203178B true ZA200203178B (en) 2003-07-22

Family

ID=20417605

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203178A ZA200203178B (en) 1999-11-03 2002-04-22 New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist.

Country Status (13)

Country Link
EP (1) EP1242065A1 (en)
JP (1) JP2003513037A (en)
KR (1) KR20020050254A (en)
CN (1) CN1387431A (en)
AU (2) AU1321401A (en)
BR (1) BR0015172A (en)
CA (1) CA2388657A1 (en)
IL (1) IL149365A0 (en)
MX (1) MXPA02004334A (en)
NO (1) NO20022103L (en)
SE (1) SE9903995D0 (en)
WO (2) WO2001032163A1 (en)
ZA (1) ZA200203178B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
AR040962A1 (en) * 2002-08-09 2005-04-27 Novartis Ag COMPOUNDS DERIVED FROM TIAZOL 1,3-2-ONA, PHARMACEUTICAL COMPOSITION AND COMPOSITE PREPARATION PROCESS
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
CA2562009A1 (en) * 2004-04-05 2005-10-20 Sepracor Inc. (r,r)-formoterol in combination with other pharmacological agents
ES2245612B1 (en) * 2004-06-29 2007-08-16 Universidad De Barcelona NEW THERAPEUTIC USE OF FORMOTEROL.
PL1863476T3 (en) * 2005-03-16 2016-07-29 Meda Pharma Gmbh & Co Kg The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
UA111198C2 (en) 2011-06-06 2016-04-11 К'Єзі Фармачеутічі С.П.А. Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as inhibitors of the phosphodiesterase
WO2014086865A1 (en) * 2012-12-05 2014-06-12 Chiesi Farmaceutici S.P.A. 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors
JP5846185B2 (en) 2013-11-21 2016-01-20 大日本印刷株式会社 Through electrode substrate and semiconductor device using the through electrode substrate
PT109030B (en) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. PREPARATION OF ZAFIRLUCAST INHALABLE PARTICULES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604752D0 (en) * 1996-12-20 1996-12-20 Astra Ab Formulation and use
WO1998039970A1 (en) * 1997-03-13 1998-09-17 Merck & Co., Inc. Quinoline leukotriene antagonists
SE9704644D0 (en) * 1997-12-12 1997-12-12 Astra Ab New use

Also Published As

Publication number Publication date
EP1242065A1 (en) 2002-09-25
IL149365A0 (en) 2002-11-10
SE9903995D0 (en) 1999-11-03
AU1652601A (en) 2001-05-14
NO20022103D0 (en) 2002-05-02
CA2388657A1 (en) 2001-05-10
AU1321401A (en) 2001-05-14
KR20020050254A (en) 2002-06-26
MXPA02004334A (en) 2002-11-07
CN1387431A (en) 2002-12-25
WO2001032166A1 (en) 2001-05-10
JP2003513037A (en) 2003-04-08
BR0015172A (en) 2002-06-18
NO20022103L (en) 2002-05-02
WO2001032163A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
HUP0101411A3 (en) A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof
AP2000001916A0 (en) 2-Adrenergic receptor agonists
ZA985678B (en) 1-amino-alkylcyclohexane NMDA receptor antagonists.
EP1100506A4 (en) Integrin receptor antagonists
EP1105389A4 (en) Integrin receptor antagonists
AU775774C (en) Peroxisome proliferator-activated receptor agonist
ZA200203178B (en) New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist.
ZA200100978B (en) Muscarinic agonists and antagonists.
EP1061921A4 (en) Vitronectin receptor antagonists
IL137930A0 (en) Benzylpiperazinyl and benzylpiperidinyl ethanone derivatives, their preparation and their use as a dopamine d4 receptor antagonists
AU5861900A (en) Receptor agonists and antagonists
AU6230698A (en) Dopamine d4 receptor antagonist
EP1102587A4 (en) Vitronectin receptor antagonists
ZA995029B (en) Estrogen agonists/antagonists.
PL351546A1 (en) 1,5−benzodiazepine derivatives as cck−a receptor agonists
AU5234899A (en) Alpha 1a adrenergic receptor antagonists
AU2003202455A1 (en) A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
HK1048803A1 (en) β 2-ADRENERGIC RECEPTOR AGONISTS
SI1235787T1 (en) $g(b)2-ADRENERGIC RECEPTOR AGONISTS
ZA200004561B (en) β 2-adrenergic receptor agonists.
ZA991884B (en) Vitronectin receptor antagonists.
ZA9610690B (en) Integrin receptor antagonists.
ZA978798B (en) Vitronectin receptor antagonists.
AUPP058597A0 (en) Receptor agonists and antagonists
GB9811283D0 (en) Vironectin receptor antagonists